Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.460
+0.010 (0.69%)
Mar 4, 2026, 1:17 PM EST - Market open
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $201.02 million as of March 4, 2026. Its market cap has increased by 148.32% in one year.
Market Cap
201.02M
Enterprise Value
176.29M
1-Year Change
148.32%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $201.02M, a decrease of -60.90%. That is a compound annual growth rate of -19.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 199.64M | 33.03% |
| Dec 31, 2025 | 150.07M | 230.61% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ClearPoint Neuro | 262.83M |
| CapsoVision | 249.67M |
| 908 Devices | 228.74M |
| CVRx, Inc. | 215.23M |
| Quantum-Si incorporated | 204.28M |
| SANUWAVE Health | 202.65M |
| Electromed | 198.44M |
| Rapid Micro Biosystems | 187.93M |